Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 1988 (1) TMI AT This

  • Login
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

1988 (1) TMI 229 - AT - Central Excise

Issues:
Interpretation of Notification No. 117/66 dated 16-7-1966 regarding the supply of patent or proprietary medicines to Government departments. Scope of benefit under the notification when goods are supplied through distributors to approved chemist shops. Whether supply to approved chemist shops is considered as directly supplying to Government departments.

Analysis:
The case involved a dispute regarding the eligibility of a company to avail the benefit of Notification No. 117/66 dated 16-7-1966 for patent or proprietary medicines supplied to the E.S.I.C. (a Government department) through distributors to approved chemist shops. The departmental authorities contended that the company did not fulfill the terms of the notification as the goods were not directly supplied to the Government department but to the approved chemist shops. The lower appellate authority initially ruled in favor of the company but remanded the matter to verify specific facts. Upon readjudication, the demands were confirmed against the company, leading to an appeal.

The appellate tribunal considered the appeal and rejected the appellant's argument. It noted that the lower appellate authority had previously decided the matter in 1978 and the scope of remand was limited to verifying specific facts. The tribunal emphasized that the term "directly" in the notification could include supply to approved chemist shops, as they serve as outlets for the Government department. Therefore, the supply to approved chemist shops was deemed equivalent to supplying directly to the Government department. Consequently, the appeal was dismissed, upholding the lower appellate authority's decision.

Overall, the tribunal's judgment clarified that supplying patent or proprietary medicines to approved chemist shops approved by Government departments could be considered as directly supplying to the Government department, making the company eligible for the benefits under the notification.

 

 

 

 

Quick Updates:Latest Updates